Summary: GLP-1 receptor agonists and other anti-obesity medications (AOMs) are valuable tools in obesity treatment, but they are not standalone solutions. Their effectiveness depends on integration into comprehensive care; achieving this requires policy reforms,...
Chronic disease management
Training Session and Guidance for Life Science Companies to Engage in Health Equity Research
Summary: A life science company engaged Atlas Clarity to develop a health equity presentation for its staff that provided guidance on who is currently engaged in health equity now, as well as how community health centers can help in aid research to improve health...
Mixed-Methods Study on Disparities in Rare Disease Patients’ Diagnostic Journeys and Proposed Solutions (Project ASPIRE)
Summary: A life science company sought to better understand patient experience with timely diagnosis and treatment of two rare diseases, neuromyelitis optica spectrum disorders (NMOSD) and generalized myasthenia gravis (gMG), particularly among underserved...
Feasibility Assessment of Social Determinants of Health Screening at Lupus Clinics
Summary: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that causes the body to attack its own organs and tissue. Due to its uncommon nature, it is often hard to diagnose, particularly in disadvantaged populations. While not typically fatal, it...
